Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1995
08/22/1995US5444053 Method for treating symptoms of Alzheimer's with NADH and NADPH
08/22/1995US5443850 Method for treating symptoms associated with vascular headaches by administering a combination of calcium and vitamin D
08/22/1995US5443839 Liposomes containing scutellaria extracts
08/22/1995CA2032231C Substituted oxophthalazinyl acetic acids and analogs thereof
08/22/1995CA2030077C Azabicyclo amides and esters as 5-ht _receptor antagonists
08/22/1995CA1336773C Therapeutic dibenzo-piperazino-azepine derivatives
08/17/1995WO1995021857A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021854A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021844A1 5ht2b receptor antagonists condensed indoles
08/17/1995WO1995021843A1 Azacyclic derivatives
08/17/1995WO1995021842A1 Heterocyclic compounds and their preparation and use
08/17/1995WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
08/17/1995WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021836A1 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
08/17/1995WO1995021821A1 New compounds with analgesic and local anaesthetic effect
08/17/1995WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995WO1995021813A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
08/17/1995WO1995021617A1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/1995WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995WO1995021609A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/17/1995CA2183231A1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/1995CA2183084A1 5-heteroarylindole derivatives
08/17/1995CA2183077A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
08/17/1995CA2182957A1 Heterocyclic compounds and their preparation and use
08/17/1995CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995CA2181461A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/17/1995CA2181068A1 New compounds with analgesic and local anaesthetic effect
08/17/1995CA2142535A1 1-[2-(1h-inden-3-yl)ethyl]-4- (naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics
08/16/1995EP0667344A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists
08/16/1995EP0667340A1 Isatine derivates, their preparation and their use as excitatory amino acid receptor antagonist
08/16/1995EP0667150A1 Venlamafaxine and its analogues for inducing cognition enhancement
08/16/1995EP0666858A1 5-arylindole derivatives and their use as serotonin (5-ht 1?) agonists
08/16/1995EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists
08/16/1995EP0666851A1 Substituted phthalazinones as nerotensin antagonists
08/16/1995EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
08/16/1995EP0666847A1 Tryptamine analogs with 5-ht1d selectivity
08/16/1995EP0666759A1 Preparation for therapeutic and especially prophylactic treatment of digestive tract disorders
08/16/1995EP0666756A1 Method of producing analgesia using neurotrophins
08/16/1995EP0666748A1 The use of inositoltrisphosphate for the preparation of medicaments
08/16/1995EP0666745A1 Diagnosis and therapy for parkinson's disease
08/16/1995EP0513174B1 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
08/16/1995CN1106813A 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity
08/16/1995CN1106812A Tricyclic diazepine vasopressin antagonists
08/16/1995CN1106811A Piperidines and piperazines
08/16/1995CN1106804A 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives
08/16/1995CN1106802A Tricyclic benzazepine vasopressin antagonists
08/16/1995CN1106656A Sustained release drug formulation containing a tramadol salt
08/15/1995US5442104 Inhibitors of kynureninase
08/15/1995US5441973 Treating cerebral functional disorders; nootropic agents
08/15/1995US5441969 Imidazole compounds, their preparation and use
08/15/1995US5441967 Cyclic amine compounds and their use
08/15/1995US5441956 Analgesics, delta opioid receptor agonists
08/15/1995CA2142411A1 Polysubstituted 3-acylamino-5-phenyl-1,4- benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
08/15/1995CA2141774A1 Venlafaxine in the inducement of cognition enhancement
08/15/1995CA2030178C Transdermal therapeutic system comprising as active component buprenorphine
08/15/1995CA1336686C Method of inhibiting onset of or treating migraine headache using a thromboxane a- receptor antagonist
08/15/1995CA1336678C Prophylaxis and treatment of nervous system diseases with melanin
08/15/1995CA1336677C Compositions having use as treatment of psoriasis and neuropsychiatric deficits
08/10/1995WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021187A1 Cyclic neurokinin a antagonists
08/10/1995WO1995021167A1 Triazole derivatives
08/10/1995WO1995021166A1 Triazole derivatives
08/10/1995WO1995021165A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
08/10/1995WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995WO1995020966A1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide
08/10/1995WO1995020964A1 Oral liquid compositions containing paroxetine resinate
08/10/1995WO1995020958A1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
08/10/1995WO1995020950A1 Therapeutic guanidines
08/10/1995WO1995017876A3 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps
08/10/1995DE4403709A1 Pharmazeutische Zusammensetzung zur systemischen transdermalen Verabreichung mit dem Wirkstoff Morphin-6-glucuronid A pharmaceutical composition for systemic transdermal administration containing the active substance of morphine-6-glucuronide
08/10/1995CA2183466A1 Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
08/10/1995CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
08/10/1995CA2182593A1 Oral liquid compositions containing paroxetine resinate
08/10/1995CA2182302A1 Therapeutic guanidines
08/10/1995CA2182197A1 Triazole derivatives
08/10/1995CA2182196A1 Triazole derivatives
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/09/1995EP0666260A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy
08/09/1995EP0666258A1 Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents
08/09/1995EP0666250A1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy
08/09/1995EP0666080A1 Treatment of autoimmune diseases by oral administration of autoantigens
08/09/1995EP0665844A1 Substituted benzylaminoquinuclidines as substance p antagonists
08/09/1995EP0665843A1 Substituted quinuclidines as substance p antagonists
08/09/1995EP0665840A1 Dopamine receptor subtype ligands
08/09/1995EP0665833A1 Dopamine receptor subtype ligands
08/09/1995EP0665830A1 Tilidin dihydrogen orthophosphate, method of preparing it and pharmaceutical preparations containing it.
08/09/1995EP0665752A1 Pharmaceutical compositions containing 3-beta-hydroxylated natural steroid derivatives, and use thereof
08/09/1995EP0665729A1 Biocompatible polymers containing diagnostic or therapeutic moieties
08/09/1995CN1106608A Controlled release preparation containing a salt of morphine
08/09/1995CN1106395A Derivative of 1,3,4-oxadiazol-2(3H)-one, preparation and pharmaceutical use of same
08/09/1995CN1106381A Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same
08/09/1995CN1106275A Chinese medicine Morinda officinalis preparation for treatment of mental disease
08/08/1995US5440048 1-piperazinyl-2-butenes and -2-butynes
08/08/1995US5439940 Benz[e]indene derivatives
08/08/1995US5439922 Piperidyl-substituted indoles for treating anxiety
08/08/1995US5439920 1,2,5,6-tetrahydropyridine derivative, process for preparing it and its applications in therapy
08/08/1995US5439895 4-aminoquinazoline derivatives
08/08/1995CA2008108C Bis-aza-bicyclic anxiolytic agents
1 ... 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 ... 1833